Gabani P, et al. - Using the National Cancer Database, researchers evaluated the patterns of care of induction chemotherapy in nasopharyngeal carcinoma (NPC) and its impact on overall survival (OS). As per findings, the use of induction therapy remained stable in the last decade. Younger patients and those with higher T- and N-stage were more frequently treated with induction chemotherapy. The 5-year OS in patients treated with induction chemotherapy and CRT was 66.3% vs 69.1%, respectively. Suggesting no association of induction chemotherapy with improved OS compared to CRT alone.